Northwest Biotherapeutics Inc SEC filings NWBO

Northwest Biotherapeutics Inc has 803 filings in SEC EDGAR's recent list, going back to Aug 13, 2001. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (material agreement, new debt). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Apr 15, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 5, 2024 Dec 31, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
10-K/A Amended annual report Jun 30, 2022 Dec 31, 2021
10-K/A Amended annual report May 2, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
10-K/A Amended annual report Jun 24, 2020 Dec 31, 2019
10-K Annual report Mar 16, 2020 Dec 31, 2019
10-K Annual report Apr 2, 2019 Dec 31, 2018
10-K Annual report Apr 17, 2018 Dec 31, 2017
10-K Annual report Apr 17, 2017 Dec 31, 2016
10-K/A Amended annual report Apr 29, 2016 Dec 31, 2015
10-K Annual report Mar 16, 2016 Dec 31, 2015
10-K/A Amended annual report Apr 30, 2015 Dec 31, 2014
10-K Annual report Mar 17, 2015 Dec 31, 2014
10-K Annual report Apr 1, 2014 Dec 31, 2013
10-K/A Amended annual report Apr 30, 2013 Dec 31, 2012
10-K Annual report Apr 8, 2013 Dec 31, 2012
10-K Annual report Apr 13, 2012 Dec 31, 2011
10-K Annual report Apr 21, 2011 Dec 31, 2010
10-K/A Amended annual report Apr 13, 2011 Dec 31, 2009
10-K/A Amended annual report Mar 2, 2011 Dec 31, 2009
10-K/A Amended annual report Jan 26, 2011 Dec 31, 2009
10-K Annual report Apr 15, 2010 Dec 31, 2009
10-K Annual report Apr 15, 2009 Dec 31, 2008
10-K Annual report Apr 15, 2008 Dec 31, 2007
10-K/A Amended annual report Dec 7, 2007 Dec 31, 2006
10-K/A Amended annual report Dec 3, 2007 Dec 31, 2006
10-K Annual report Apr 17, 2007 Dec 31, 2006
10-K/A Amended annual report Jun 30, 2006 Dec 31, 2004
10-K Annual report Apr 18, 2006 Dec 31, 2005
10-K Annual report Apr 15, 2005 Dec 31, 2004
10-K Annual report May 14, 2004 Dec 31, 2003
ARS Annual report to shareholders Mar 26, 2003 Dec 31, 2002
10-K Annual report Mar 21, 2003 Dec 31, 2002

Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NWBO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bethesda, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1072379

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.